Smarter rather than stronger treatment of haematological malignancies and non-malignant indications for stem-cell transplantation

This publication has 9 references indexed in Scilit:

• Immunotherapy of cancer with alloreactive lymphocytes
  The Lancet Oncology, 2001
• Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases
  Critical Reviews in Oncology/Hematology, 2001
• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
  Blood, 2001
• NON-MYELOABLATIVE STEM CELL TRANSPLANTATION AND DONOR LYMPHOCYTE INFUSION FOR THE TREATMENT OF CANCER AND LIFE-THREATENING NON-MALIGNANT DISORDERS
  Reviews in Clinical and Experimental Hematology, 2001
• Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy
  British Journal of Haematology, 2000
• Mini-allografts: ongoing trials in humans
  Bone Marrow Transplantation, 2000
• Minitransplants and cell-based therapies for malignant and nonmalignant disorders
  Current Opinion in Organ Transplantation, 1999
• Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
  Blood, 1998
• Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
  Journal of Clinical Oncology, 1997